Scientific and clinical progress together with the development of effective novel therapeutic
options has engendered multiple important changes in the diagnosis and management of …

Hereditary Angioedema (HAE) is a rare and disabling disease for which early diagnosis and
effective therapy are critical. This revision and update of the global WAO/EAACI guideline on …

Background The treatment of hereditary angioedema (HAE) has undergone dramatic
changes as newer medicines have become available in recent years. Optimal care of these …

Hereditary Angioedema (HAE) is a rare and disabling disease. Early diagnosis and
appropriate therapy are essential. This update and revision of the global guideline for HAE …

This is an update to the 2014 Canadian Hereditary Angioedema Guideline with an
expanded scope to include the management of hereditary angioedema (HAE) patients …

In light of the remarkable progress recently achieved in our understanding of angioedema,
the American Academy of Allergy, Asthma and Immunology, American College of Allergy …

Abstract Background We published the Canadian 2003 International Consensus Algorithm
for the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor …

Hereditary angioedema (HAE) is a rare disease that causes episodic attacks of
subcutaneous and submucosal edema, which can be painful, incapacitating, and potentially …

Hereditary angioedema (HAE) is a chronic disease with a high burden of disease that is
poorly understood and often misdiagnosed. Availability of treatments, including C1 esterase …

Objective Hereditary angioedema (HAE) is a rare genetic disease characterized by long-
term recurrent attacks of subcutaneous or submucosal edema in different parts of the body …